Dennis J. Slamon
APLA Health(US)University of California, Los Angeles(US)UCLA Health(US)UCLA Health(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Lung Cancer Research Studies
Most-Cited Works
- → Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene(1987)11,680 cited
- → Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2(2001)11,439 cited
- → Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer(1989)6,838 cited
- → Palbociclib and Letrozole in Advanced Breast Cancer(2016)2,879 cited
- → Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease(1999)2,788 cited
- → Adjuvant Trastuzumab in HER2-Positive Breast Cancer(2011)2,750 cited